Enorama Pharma AB OMXSTO:ERMA:
POSTPONES PUBLICATION OF 2025 REPORT TO MARCH 18, 2026 DUE TO PREPARATION OF CONTROL BALANCE SHEET
Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
Earlier from Enorama Pharma Ab
- Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting
- Enorama Pharma Enters Loan Agreement With DS Global
- Enorama Pharma Postpones Its 2025 Year-End Report
- Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision